147 related articles for article (PubMed ID: 34823305)
21. Marking Disappearing Colorectal Liver Metastases After Complete Response to Neoadjuvant Chemotherapy
Vujic J; Schöllnast H; Marsoner K; Wienerroither V; Bacher H; Mischinger HJ; Kornprat P
Anticancer Res; 2019 Jul; 39(7):3847-3854. PubMed ID: 31262912
[TBL] [Abstract][Full Text] [Related]
22. The Influence of Radiological "Disappearing Lesions" on the Efficacy and Prognosis of Patients with Colorectal Liver Metastases Undergoing Conversion Therapy.
Song ZY; Yang D; Liu Y; Cheng Y
Gastroenterol Res Pract; 2022; 2022():2200598. PubMed ID: 35242182
[TBL] [Abstract][Full Text] [Related]
23. A comparison of diagnostic imaging modalities for colorectal liver metastases.
Bonanni L; de'Liguori Carino N; Deshpande R; Ammori BJ; Sherlock DJ; Valle JW; Tam E; O'Reilly DA
Eur J Surg Oncol; 2014 May; 40(5):545-550. PubMed ID: 24491289
[TBL] [Abstract][Full Text] [Related]
24. A radiological footprint equivalent to liquefactive necrosis observed in the course of disappearing liver metastases in rectal cancer: A case report and review of the literature.
Yamada K; Fujita Y; Amagai T
Radiol Case Rep; 2022 Jul; 17(7):2583-2588. PubMed ID: 35685302
[TBL] [Abstract][Full Text] [Related]
25. Treatment of liver metastases, an update on the possibilities and results.
Ruers T; Bleichrodt RP
Eur J Cancer; 2002 May; 38(7):1023-33. PubMed ID: 11978527
[TBL] [Abstract][Full Text] [Related]
26. Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trial.
Folprecht G; Gruenberger T; Bechstein WO; Raab HR; Lordick F; Hartmann JT; Lang H; Frilling A; Stoehlmacher J; Weitz J; Konopke R; Stroszczynski C; Liersch T; Ockert D; Herrmann T; Goekkurt E; Parisi F; Köhne CH
Lancet Oncol; 2010 Jan; 11(1):38-47. PubMed ID: 19942479
[TBL] [Abstract][Full Text] [Related]
27. [Choice of surgical strategy for colorectal liver metastases depending on clinical and pathological response to neoadjuvant chemo- and targeted therapy].
Jakab F
Orv Hetil; 2010 Nov; 151(47):1956-60. PubMed ID: 21071308
[TBL] [Abstract][Full Text] [Related]
28. Assessment of the response to systemic treatment of colorectal liver metastases on cross-sectional imaging - a systematic review.
Morawska I; Cieszanowski A
Pol J Radiol; 2023; 88():e512. PubMed ID: 38125815
[TBL] [Abstract][Full Text] [Related]
29. Intraoperative ultrasonographic detection of occult liver metastases in colorectal cancer.
Stadler J; Hölscher AH; Adolf J
Surg Endosc; 1991; 5(1):36-40. PubMed ID: 1871673
[TBL] [Abstract][Full Text] [Related]
30. Combined use of intraoperative ultrasound and indocyanine green fluorescence imaging to detect liver metastases from colorectal cancer.
Peloso A; Franchi E; Canepa MC; Barbieri L; Briani L; Ferrario J; Bianco C; Quaretti P; Brugnatelli S; Dionigi P; Maestri M
HPB (Oxford); 2013 Dec; 15(12):928-34. PubMed ID: 23458105
[TBL] [Abstract][Full Text] [Related]
31. A New Technique of Radiofrequency-assisted Ultrasound-guided Needle-localized Laparoscopic Resection of Disappearing Colorectal Liver Metastases.
Yigitbas H; Yazici P; Taskin HE; Okoh AK; Dural C; Aydin N; Berber E
Surg Laparosc Endosc Percutan Tech; 2017 Feb; 27(1):e1-e5. PubMed ID: 28145969
[TBL] [Abstract][Full Text] [Related]
32. A radiologist's point of view in the presurgical and intraoperative setting of colorectal liver metastases.
Granata V; Fusco R; Avallone A; Catalano O; Piccirillo M; Palaia R; Nasti G; Petrillo A; Izzo F
Future Oncol; 2018 Sep; 14(21):2189-2206. PubMed ID: 30084273
[TBL] [Abstract][Full Text] [Related]
33. Liver metastases of colorectal cancer: US, CT or MR?
Schima W; Kulinna C; Langenberger H; Ba-Ssalamah A
Cancer Imaging; 2005 Nov; 5 Spec No A(Spec No A):S149-56. PubMed ID: 16361131
[TBL] [Abstract][Full Text] [Related]
34. Disappearing colorectal liver metastases: Strategies for the management of patients achieving a radiographic complete response after systemic chemotherapy.
Araujo RLC; Milani JM; Armentano DP; Moreira RB; Pinto GSF; de Castro LA; Lucchesi FR
J Surg Oncol; 2020 Apr; 121(5):848-856. PubMed ID: 31773747
[TBL] [Abstract][Full Text] [Related]
35. [Management of synchronous colorectal liver metastases].
Dupré A; Gagnière J; Chen Y; Rivoire M
Bull Cancer; 2013 Apr; 100(4):363-71. PubMed ID: 23559319
[TBL] [Abstract][Full Text] [Related]
36. Early PET/CT scan is more effective than RECIST in predicting outcome of patients with liver metastases from colorectal cancer treated with preoperative chemotherapy plus bevacizumab.
Lastoria S; Piccirillo MC; Caracò C; Nasti G; Aloj L; Arrichiello C; de Lutio di Castelguidone E; Tatangelo F; Ottaiano A; Iaffaioli RV; Izzo F; Romano G; Giordano P; Signoriello S; Gallo C; Perrone F
J Nucl Med; 2013 Dec; 54(12):2062-9. PubMed ID: 24136935
[TBL] [Abstract][Full Text] [Related]
37. The impact of intraoperative ultrasonography on the management of disappearing colorectal liver metastases.
Giuliante F; Panettieri E; Ardito F
Hepat Oncol; 2015 Oct; 2(4):325-328. PubMed ID: 30191012
[No Abstract] [Full Text] [Related]
38. Managing synchronous liver metastases from colorectal cancer: a multidisciplinary international consensus.
Adam R; de Gramont A; Figueras J; Kokudo N; Kunstlinger F; Loyer E; Poston G; Rougier P; Rubbia-Brandt L; Sobrero A; Teh C; Tejpar S; Van Cutsem E; Vauthey JN; Påhlman L;
Cancer Treat Rev; 2015 Nov; 41(9):729-41. PubMed ID: 26417845
[TBL] [Abstract][Full Text] [Related]
39. Neoadjuvant chemotherapy affects staging of colorectal liver metastasis--a comparison of PET, CT and intraoperative ultrasound.
Spatz J; Holl G; Sciuk J; Anthuber M; Arnholdt HM; Märkl B
Int J Colorectal Dis; 2011 Feb; 26(2):165-71. PubMed ID: 20960208
[TBL] [Abstract][Full Text] [Related]
40. Imaging and treatment of patients with colorectal liver metastases in the Netherlands: a survey.
Bipat S; van Leeuwen MS; Ijzermans JN; Bossuyt PM; Greve JW; Stoker J
Neth J Med; 2006 May; 64(5):147-51. PubMed ID: 16702613
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
